Navigation Links
Hospira to Present at Upcoming Investor Conferences
Date:2/14/2011

LAKE FOREST, Ill., Feb. 14, 2011 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced that the company will present at two upcoming conferences:


  • Raymond James 32nd Institutional Investors Conference


  • March 8, 2011 (Tuesday) – Orlando, Fla.  9:15 a.m. Eastern time


  • Barclays Capital 2011 Global Healthcare Conference


  • March 16, 2011 (Wednesday) – Miami, Fla.:45 a.m. Eastern timeThe presentations will be available to all interested parties through live audiocasts accessible via the investor relations section of Hospira's Web site at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance of each presentation to ensure proper setup to receive the audiocast. The slides accompanying the presentations will also be available on the Hospira Web site. Replays of the webcasts will be available on the Hospira Web site approximately 24 hours after the live presentations.

    Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness™. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.


    '/>"/>
    SOURCE Hospira, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1

    Related medicine technology :

    1. Hospira Announces FDA Approval of Topotecan Injection
    2. Hospira Reports Fourth-Quarter and Full-Year 2010 Results
    3. Hospira to Host Conference Call for Fourth-Quarter 2010 Results and 2011 Projections
    4. Hospira Launches Piperacillin and Tazobactam for Injection in the United States
    5. Hospira Announces New Contracts in Effect with Novation for Infusion Pumps, Solutions and Equipment
    6. Hospira to Host Conference Call for Third-Quarter 2010 Results
    7. Hospira Receives TGA Approval for Nivestim™, Australias First Biosimilar Filgrastim
    8. Hospira Japan Receives Approval for New Indication for Precedex IV™ 200ug
    9. Hospira Announces CEO Succession Plan
    10. Hospira to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Aug. 12
    11. Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
    (Date:6/23/2016)...  In a startling report released today, National Safety Council ... a comprehensive, proven plan to eliminate prescription opioid overdoses. ... states are tackling the worst drug crisis in recorded U.S. history, ... Kentucky , New Mexico , ... the 28 failing states, three – Michigan , ...
    (Date:6/23/2016)... June 23, 2016 Bracket , a leading ... next generation clinical outcomes platform, Bracket eCOA (SM) 6.0, ... June 26 – 30, 2016 in Philadelphia ... Clinical Outcome Assessment product of its kind to fully integrate ... Bracket eCOA 6.0 is a flexible platform for electronic ...
    Breaking Medicine Technology:
    (Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
    (Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding ... of its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. ... James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. ...
    (Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
    (Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
    (Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
    Breaking Medicine News(10 mins):